Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 3/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15539608 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL16727813 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL13238229 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL15540189 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL817926 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL16727811 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL17212370 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL24419237 | 0.89 | ALDH1A1 (0.38) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL15999633 | 0.89 | TSHR (0.39) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| SCHEMBL19478755 | 0.88 | ALDH1A1 (0.41) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242702-A1 | METHOD FOR OBTAINING BIOSOURCED POLYEPOXIDES WITH IMPROVED PROPERTIES | ROQUETTE FRERES (FR) | 2023-08-03 | — | — | US | disclosed |
| US-20230242702-A1 | METHOD FOR OBTAINING BIOSOURCED POLYEPOXIDES WITH IMPROVED PROPERTIES | ROQUETTE FRERES (FR) | 2023-08-03 | — | — | US | disclosed |
| WO-2022002438-A1 | METHOD FOR OBTAINING BIOSOURCED POLYEPOXIDES WITH IMPROVED PROPERTIES | ROQUETTE FRERES (FR) | 2022-01-06 | — | — | WO | disclosed |
| US-10174152-B2 | Process for producing isohexide glycidyl ethers, products thus obtained, and uses thereof | ROQUETTE FRERES (FR) | 2019-01-08 | — | — | US | disclosed |
| US-9643157-B2 | Hydrogel composition | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2017-05-09 | — | — | US | disclosed |
| US-9643157-B2 | Hydrogel composition | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2017-05-09 | — | — | US | disclosed |
| US-9605108-B2 | Isosorbide-derived epoxy resins and methods of making same | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2017-03-28 | — | — | US | disclosed |
| US-9605108-B2 | Isosorbide-derived epoxy resins and methods of making same | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2017-03-28 | — | — | US | disclosed |
| US-20170050172-A1 | Hydrogel Composition | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2017-02-23 | — | — | US | disclosed |
| US-20170002132-A1 | PROCESS FOR PRODUCING ISOHEXIDE GLYCIDYL ETHERS, PRODUCTS THUS OBTAINED, AND USES THEREOF | ROQUETTE FRERES (FR) | 2017-01-05 | — | — | US | disclosed |
| US-20170002132-A1 | PROCESS FOR PRODUCING ISOHEXIDE GLYCIDYL ETHERS, PRODUCTS THUS OBTAINED, AND USES THEREOF | ROQUETTE FRERES (FR) | 2017-01-05 | — | — | US | disclosed |
| US-9504987-B2 | System and method for superabsorbent material | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2016-11-29 | — | — | US | disclosed |
| US-20150307650-A1 | ISOSORBIDE-DERIVED EPOXY RESINS AND METHODS OF MAKING SAME | NEW JERSEY INSTITUTE OF TECHNOLOGY | 2015-10-29 | — | — | US | disclosed |
| EP-2301941-B1 | Isosorbide glyceryl ether derivatives and their use in household applications | COGNIS IP MAN GMBH (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-8420588-B2 | Isosorbide glyceryl ether derivatives and their use in household applications | COGNIS IP MANAGEMENT GMBH (DE) | 2013-04-16 | — | — | US | disclosed |
| US-8420588-B2 | Isosorbide glyceryl ether derivatives and their use in household applications | COGNIS IP MANAGEMENT GMBH (DE) | 2013-04-16 | — | — | US | disclosed |
| US-20120172282-A1 | Isosorbide Glyceryl Ether Derivatives And Their Use In Household Applications | COGNIS IP MANAGEMENT GMBH (DE) | 2012-07-05 | — | — | US | disclosed |
| US-20120172282-A1 | Isosorbide Glyceryl Ether Derivatives And Their Use In Household Applications | COGNIS IP MANAGEMENT GMBH (DE) | 2012-07-05 | — | — | US | disclosed |
| EP-2301941-A1 | Isosorbide glyceryl ether derivatives and their use in household applications | Cognis IP Management GmbH (DE) | 2011-03-30 | — | — | EP | disclosed |
| WO-2011029548-A1 | ISOSORBIDE GLYCERYL ETHER DERIVATIVES AND THEIR USE IN HOUSEHOLD APPLICATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242702-A1 | METHOD FOR OBTAINING BIOSOURCED POLYEPOXIDES WITH IMPROVED PROPERTIES | EPHX2, EPHX1, TET3 | TSHR 4774/4885ALDH1A1 176/4885MAPK1 4737/4885 |
| US-10174152-B2 | Process for producing isohexide glycidyl ethers, products thus obtained, and uses thereof | GALE, DDOST, GYPA | TSHR 3974/4885ALDH1A1 3167/4885MAPK1 3897/4885 |
| US-20170002132-A1 | PROCESS FOR PRODUCING ISOHEXIDE GLYCIDYL ETHERS, PRODUCTS THUS OBTAINED, AND USES THEREOF | GALE, DDOST, GYPA | TSHR 3974/4885ALDH1A1 3167/4885MAPK1 3897/4885 |
| US-20120172282-A1 | Isosorbide Glyceryl Ether Derivatives And Their Use In Household Applications | MGLL, DAGLA, DAGLB | TSHR 3856/4885ALDH1A1 1714/4885MAPK1 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.